Therapies delivered via technology have been developed to improve accessibility, however, there is limited research regarding messaging therapy in particular, and none that we know of utilizing a longitudinal effectiveness design. The aim of this study was to investigate the overall effectiveness of messaging therapy, identify any contributors to its effectiveness, and to evaluate a dosage effect for this type of treatment.
Study Type
OBSERVATIONAL
Enrollment
12,980
Behavioral psychotherapy delivered by asynchronous message using the Talkspace application
Change from Baseline in Depressive symptoms on the Patient Health Questionnaire - 9
Patient Health Questionnaire - 9 (PHQ-9) is a measure of depression symptoms. It has 9 items, with a minimum of 0 and a maximum of 27, with higher scores indicating more symptoms and distress. Decreasing scores indicate better outcome. All items are summed to give the summary score.
Time frame: Up to 52 weeks
Change from Baseline in Anxiety symptoms on the Generalized Anxiety Disorder - 7
Generalized Anxiety Disorder - 7 (GAD-7) is a measure of anxiety symptoms. It has 7 items, with a minimum of 0 and a maximum of 21, with higher scores indicating more symptoms and distress. Decreasing scores indicate better outcome. All items are summed to give the summary score.
Time frame: Up to 52 weeks
Mean number of words sent from patient to therapist
Word counts of the words contained within messages sent
Time frame: Up to 52 weeks
Mean number of words sent from therapist to patient
Word counts of the words contained within messages sent
Time frame: Up to 52 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.